BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240131T160000
DTEND;TZID=Europe/London:20240131T170000
DTSTAMP:20261008T033744
CREATED:20240124T211453Z
LAST-MODIFIED:20240124T211453Z
UID:3490486-1706716800-1706720400@patientworthy.com
SUMMARY:Cell & Gene Therapy Insights' The Role of AI in Predicting Stem Cell Donor Availability Webinar
DESCRIPTION:The Role of AI in Predicting Stem Cell Donor Availability Webinar\nJanuary 31\, 2024 \nThe success of unrelated donor stem cell transplants depends on not only finding genetically matched donors but also donor availability. On average\, 50% of potential donors in the National Marrow Donor Program database are unavailable for a variety of reasons after initially matching a patient\, with significant variations in availability among subgroups (e.g.\, by race or age). Several studies have established univariate donor characteristics associated with availability. Individual consideration of each applicable characteristic is laborious\, and extrapolating group averages to the individual donor level tends to be highly inaccurate. In the current environment with enhanced donor data collection\, there are better ways to make estimates of individual donor availability. It’s about donor quality vs. quantity. \nThe presenter and panel will discuss how bioinformatics\, world-class partners\, and technology are making the search better. Specifically\, how a ground-breaking AI-based approach like the Donor Readiness Score (DRS) can predict the availability of every registered donor and evaluate the predictive power during donor selection to reduce the time to transplant. Essentially\, this approach changes how the industry considers donors\, from quantity to quality. \nAttend this webinar to learn how to: \n\nPredict an individual donor’s availability to move forward to donation\nMatch these predictions to provide a cumulative probability of search productivity and the likelihood of having an 8/8\, 7/8\, 10/10\, or 9/10 matched available donor\nAutomatically take into account multiple donor features like age\, gender\, geographical location\, race\, ethnicity\, and many more\nEnhance your accuracy and effectiveness in producing a candidate donor pool for cell/source selection that would be available when called to donate\nImprove multiple stages of the cellular therapy experience\n\nTo sign up\, click here.
URL:https://patientworthy.com/event/cell-gene-therapy-insights-role-ai-stem-cell/
CATEGORIES:Rare Disease
END:VEVENT
END:VCALENDAR